RNA-Seq in Drug Discovery and Development 1st Edition

RNA-Seq in Drug Discovery and Development, 1st Edition by Feng Cheng is an essential, practical guide for scientists and decision-makers who want to harness transcriptomics for modern drug research. Clear, authoritative, and forward-looking, this volume connects next-generation sequencing technologies to real-world applications across discovery, preclinical development, and translational medicine.

Start here if you need concise, actionable insights into experimental design, data interpretation, biomarker identification, and pathway analysis. The book demystifies RNA-Seq workflows and highlights how transcriptome profiling accelerates target validation, candidate selection, toxicity assessment, and pharmacogenomics—making it invaluable for pharmaceutical teams, biotech innovators, and academic researchers.

Readers will benefit from practical strategies for integrating RNA-Seq into lead optimization, companion diagnostics, and precision-medicine initiatives. Emphasis on reproducible analysis, quality control, and interpretation ensures findings translate from bench to clinic. Whether you work in a lab in North America, Europe, or Asia, or collaborate across global research networks, this resource helps you apply transcriptomic data to real drug-development challenges.

If your goal is to improve target selection, reduce late-stage attrition, or develop translational biomarkers, Feng Cheng’s book provides the methodological clarity and strategic perspective to get there. Packed with contemporary examples and expert guidance, it’s a must-have for researchers, bioinformaticians, and project leaders focused on RNA-Seq-driven innovation.

Order your copy today to empower your drug-discovery pipeline with the transcriptomic insights that define 21st-century pharmaceutical research.

Note: eBooks do not include supplementary materials such as CDs, access codes, etc.